4D Molecular Therapeutics, Inc. (FDMT) › Capital Expenditures4D Molecular Therapeutics, Inc. (FDMT) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2019: $3.20M2020: $1.00M2021: $9.11M2022: $11.54M2023: $2.77M2024: $3.79M2025: $536.0K$536.0K2019Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$536.0K-85.8%2024$3.79M+36.6%2023$2.77M-76.0%2022$11.54M+26.6%2021$9.11M+811.0%2020$1.00M-68.8%2019$3.20M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share